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Temporal and spatial patterns of pathological changes such as loss of neurons and 
presence of pathological protein aggregates are characteristic of neurodegenerative 
diseases such as Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, 
Alzheimer’s disease and Parkinson’s disease. These patterns are consistent with the 
propagation of protein misfolding and aggregation reminiscent of the prion diseases. 
There is a surge of evidence that suggests that large protein aggregates of a range of 
proteins are able to enter cells via macropinocytosis. Our recent work suggests that 
this process is activated by the binding of aggregates to the neuron cell surface. The 
current review considers the potential role of cell surface receptors in the triggering of 
macropinocytosis by protein aggregates and the possibility of utilizing 
macropinocytosis pathways as a therapeutic target. 
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Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), 
Frontotemporal Dementia (FTD), Alzheimer’s disease, and Parkinson’s disease have 
temporal and spatial patterns of pathological changes such as loss of neurons and 
presence of pathological protein aggregates
1-4
.  The patterns that have been identified 
in neuropathological studies are have been suggested to be consistent with 




Evidence from in vitro studies suggests that large protein aggregates of a range of 
proteins (SOD1, tau, α-synuclein, and proteins containing expanded polyglutamine 
repeats) are able to enter cells via an incompletely understood mechanism and 
propagate misfolding and aggregation
6-14
. Animal studies demonstrate that injection 
of brain or spinal cord extracts from transgenic mice expressing human tau, SOD1 or 
α-synuclein can seed pathology in transgenic mice at the sites of injection and initiate 
spread of pathology to other regions of the nervous system
14-17
. These data combined 
with the patterns of neurodegeneration provide strong evidence of prion-like protein 
misfolding propagation in neurodegenerative diseases such as Parkinson’s disease and 
ALS. The precise mechanism of cell-to-cell propagation of protein misfolding in vivo 
remains unclear. There are several possible scenarios that may explain the 
propagation of protein misfolding, the most commonly proposed of which is the 
release of protein aggregates in to the extracellular space and subsequent uptake in to 
nearby or connected naïve neurons where seeding can then take place. In this model 
both aggregate release and subsequent uptake are requisite. Misfolded or aggregated 
material may be released from cells via an active mechanism, either within exosomes 
or naked, or alternatively, aggregates may be passively released from dead or dying 
cells. In reality, within a complex biological system it is likely that the release of 
aggregated protein may be a combination of each of the possible release mechanisms. 
This makes therapeutic targeting of aggregate release difficult, moreover, reducing 
the burden of misfolded protein by active release may be beneficial to the cell and 
thus its blockade detrimental. One aspect of protein misfolding propagation that may 
provide a more tractable therapeutic target is the entry of protein aggregates in to 
cells.  
 
Work to date suggests that macropinocytosis may be responsible for the uptake of 
protein aggregates associated with various neurodegenerative diseases
6, 11, 18-21




































range of studies examining several different types of protein aggregates, including 
those made from α-synuclein, Huntingtin (exon1Q44), and tau are consistent with an 
unconventional, bulk endocytosis route being responsible for their uptake
12, 18, 22-25
. A 
systematic study using SOD1 aggregates by Münch et. al conlcuded that protein 
aggregates enter into N2A cells via macropinocytosis
19
. These findings were 
subsequently corroborated in work that showed uptake of both extracellular wildtype 
and mutant SOD1 soluble forms into NSC-34 cells can be inhibited by small molecule 
inhibitors of macropinocytosis EIPA and rottlerin
11, 20
. EIPA (5-(N-Ethyl-N-




 exchangers which 
suppresses macropinocytosis due to the vulnerability of GTPase Rac1 to pH 
changes
26
. However, the small molecule inhibitors generally utilized to define 
macropinocytosis, such as EIPA, are not specific and have been shown to prevent 
various forms of endocytosis
27
. As a result, further work is required to more precisely 
define the precise mode of endocytosis responsible for protein aggregate uptake.  
 
Macropinocytosis is a type of endocytosis that is partly defined by pinosome size, 
macropinosomes can be several micron in diameter. Macropinocytosis can be 
constitutive or a transient process, generally triggered by growth factors but has been 
observed to be activated by particles such as bacteria, apoptotic bodies and viruses
28
. 
Its activation leads to formation of large membrane ruffles that can fold back on the 
cell allowing the internalisation of fluid, membrane and other particles into large 
vacuoles several micron in diameter
29
. The role of stimulation of macropinocytosis in 
aggregate uptake remains unclear. 
 
Our recent work shows that SOD1 aggregates can bind to the cell surface and trigger 
activation of membrane ruffling in NSC-34 cells and iPSC generated human neurons 
21
 consistent with stimulated rather than constitutive macropinocytosis. The 
engulfment of aggregates in to macropinosomes could explain the ease by which 
aggregates enter the cytosol. Macropinosomes are considered ‘leaky’ due to their lack 
of physical structure compared with coated vesicles
30
. Indeed, we observed vesicle 
rupture upon entry of SOD1 aggregates in to NSC-34 cells
21
.  A characteristic 
signaling molecule associated with actin mobilization during macropinocytosis in the 
Rho GTPase Rac1. We found that application of SOD1 aggregates to NSC-34 cells 




































uptake of aggregated SOD1 in to NSC-34 and human iPSC derived motor neurons 
was suppressed by the Rac1 inhibitor W56
21
.  These data are consistent with a 
triggering of macropinocytosis that involves an activation of Rac1. Moreover, our 
data indicate that aggregates made from other proteins such as α-synuclein, 
huntingtin-polyQ and TDP-43 also trigger membrane ruffling and macropinocytosis
21
. 
Indeed, this seems to be a generic response to cell surface interaction with protein 
aggregates since aggregates made from α-lactalbumin, that are not involved with 
disease, also trigger this response. 
 
The question of how protein aggregates trigger macropinocytosis remains 
unanswered. To begin to shed light on the answer to this question one can turn to the 
virus uptake literature as the mechanisms of macropinocytosis activation have been 
more closely studied in this context. There are a several viruses
28
 that have been 
shown to utilise macropinocytosis pathways to enter cells, including the Japanese 
encephalitis virus in neurons
31
.  Receptor complexes on the cell surface are vital to the 





, and the heparan sulfate proteoglycans
34
 have been reported to be involved in 





been implicated in the triggering of the signalling cascade that stimulates 
macropinocytosis (Figure 1A). Little is known about the receptors that mediate 
protein aggregate induced macropinocytosis in neurons. However, heparan sulfate 
proteoglycans have been identified as an important part of the mechanism that allows 
tau, α-synuclein and prion protein aggregate uptake
18, 37, 38
 suggesting that the receptor 
complexes involved may be similar to that involved in virus particle uptake. 
 
While little is known about the neuronal receptor complexes associated with binding 
of protein aggregates, a wide range of receptors have been shown to be involved in 
the binding of protein aggregates to the cell surface of microglia
39, 40
.  A group of 
receptors, known as pattern recognition receptors, are often responsible for this 
process. These receptors bind to pathogen-associated molecular patterns (PAMPs) 
and danger associated molecular patterns (DAMPs) that may be responsible for the 
recognition of protein aggregates. It is possible that these pattern recognition 
receptors bind to the repetitive patterns found on aggregates formed from various 




































core structure. The binding of particles to these microglial receptor complexes results 
in activation of signalling cascades, including activation of MAP kinase and ERK1/2, 
subsequently resulting in cytokine release
41





the receptor for advanced glycation end products (RAGE)
44, 45
, integrin α6β1-integrin 
and integrin associated CD47
40





, CD14 and Toll-like receptors (TLR) 2/4
48
 have all 
been shown to be involved in microglial binding of protein aggregates made of Aβ 
peptide.  In addition, we have previously shown that microglia binding of aggregated 
SOD1 is supressed by pre-treatment with methyl-β-cyclodextrin (MβCD), fucoidan 
and lipopolysaccharide (LPS) suggesting that binding is dependent on lipid raft 
formation, scavenger receptors and CD14
49
.  The binding of fibrils to microglial cell 
surface is mediated not by individual receptors but though large receptor complexes 
(Figure 1B) involving signalling receptors such as TLR2/4.  This process of receptor 














receptor tyrosine kinases such as EphA2 and EphA4
54
. This is consistent with neurons 
having all the machinery to bind aggregates and to trigger macropinocytosis with a 
receptor complex similar to that involved in viral uptake and somewhat similar to that 
of microglial cell surface recognition (Figure 1C). Indeed, a macropinocytosis-like 
process regulates growth cone membrane recycling, growth cone collapse, axon 
retraction and turning during development and injury
55-59
.  Future work will be needed 
to further characterise the composition of the neuron specific set of cell surface 
proteins that are responsible for the binding, triggering of macropinocytosis and 
uptake of protein aggregates. Given that blocking all macropinocytosis in the brain, 
including microglial and astrocytic, may be detrimental this knowledge could be used 
to define a specific target to block neuronal uptake of protein aggregates. Blocking 
uptake may effectively supress propagation of protein aggregation, as the cytoplasmic 
invasion of protein aggregates, like those of SOD1, are a necessary part of the prion-
like propagation process. However, due to the role of a macropinocytic process in 
growth cone and axon development
55-59
 the effect of inhibition of macropinocytosis 
on neurogenesis should be studied. Regardless, a receptor tyrosine kinase EphA4 has 




































was found to inversely correlate with disease onset and survival, and loss-of-function 
mutations in EPHA4 were found to be associated with slower disease progression and 
longer survival
60
.  It is tempting to speculate that EphA4 might contribute to the 
activation of macropinocytosis and uptake of protein aggregates, which might be 
slowed in its absence or inhibition. Identifying such a target that will supress the 
neuronal macropinocytosis of protein aggregates but will allow the microglial 
phagocytosis and degradation of such particles is vital. Blocking all endocytosis of 
aggregates may be detrimental.  
 
In summary, propagation of protein misfolding and aggregation is implicated in the 
progressive nature of several neurodegenerative diseases such as Alzheimer’s disease, 
Parkinson’s disease and ALS. In order for propagation to proceed aggregates must be 
able to gain access to the cytosol of naïve neurons and current evidence suggests that 
stimulated macropinocytosis is responsible for this uptake. The receptor complexes 
responsible for this are still to be defined, but this information may provide 
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Figure 1. Cell surface receptors responsible for macropinocytosis and protein 
aggregate recognition. A) Receptor tyrosine kinases (RTK), integrins (INT) and 
heparan sulfate proteoglycans (HS) have been associated with the viral particle 
recognition and subsequent triggering of macropinocytosis. B) Scavenger receptors 
(SR), RAGE, integrins (INT), CD14 and toll like receptors (TLR) have all been found 
to play a role in recognition and subsequent proinflammatory response to protein 
aggregates of amyloid β peptide. C) Neurons have been shown to express scavenger 
receptors (SR), receptor tyrosine kinases (RTK), integrins (INT) and heparan sulfate 
proteoglycans which may be involved in triggering of macropinocytosis by protein 
aggregates.  
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